These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 10174423)
1. The economic value of individualizing drug therapy. Navarro RP Manag Care Interface; 1997 Oct; 10(10):96-8. PubMed ID: 10174423 [No Abstract] [Full Text] [Related]
2. Pharmacologically rich clinical decision support provides extra measure for managed care success. Jacobs CM Med Interface; 1997 Jun; 10(6):70-2. PubMed ID: 10169011 [TBL] [Abstract][Full Text] [Related]
3. Advancing economic evaluations of drug therapy. Navarro RP Med Interface; 1996 Jul; 9(7):86-7, 92. PubMed ID: 10159281 [No Abstract] [Full Text] [Related]
4. Pharmacotherapy: strategies to control drug costs in managed care. Monane M; Nagle B; Kelly MA Geriatrics; 1998 Sep; 53(9):51-4, 63; quiz 64. PubMed ID: 9745626 [TBL] [Abstract][Full Text] [Related]
5. Pharmacoeconomics: determining the value of drug therapy. Peterson C Healthplan; 1998; 39(3):44-50. PubMed ID: 10181751 [No Abstract] [Full Text] [Related]
6. Medication restrictions: feeling the side effects. Fitzpatrick C Behav Healthc Tomorrow; 2001 Oct; 10(5):14-7, 39-40. PubMed ID: 11594068 [No Abstract] [Full Text] [Related]
7. Using provider practice profiles as preventative care for medical costs. Baker SJ; Helsel EV Infocare; 1994 Jun; ():42-4, 46. PubMed ID: 10144404 [No Abstract] [Full Text] [Related]
8. Assessing the economic value of antihypertensive medications. Roth MS; Davenport RC; Simpson W Am J Manag Care; 1998 Sep; 4(9):1267-75. PubMed ID: 10185977 [TBL] [Abstract][Full Text] [Related]
9. Risk contractors take aim at skyrocketing drug costs. Capitation Manag Rep; 1998 Sep; 5(9):129-34. PubMed ID: 10186047 [No Abstract] [Full Text] [Related]
10. Integrating disease state management and pharmaceutical care for cost-effective quality care. Dillon MJ Med Interface; 1995 Oct; 8(10):71, 79. PubMed ID: 10152325 [No Abstract] [Full Text] [Related]
11. Implications of disease management in the future of managed care. Zalta E; Eichner H; Henry M Med Interface; 1994 Dec; 7(12):66-9, 78. PubMed ID: 10139403 [TBL] [Abstract][Full Text] [Related]
12. Managing prescription drug costs. Sica JM Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515 [TBL] [Abstract][Full Text] [Related]
13. Specialty pharmaceuticals: developing a management plan. Willcutts D Manag Care Q; 2002; 10(4):26-9. PubMed ID: 12561391 [TBL] [Abstract][Full Text] [Related]
14. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails. Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377 [TBL] [Abstract][Full Text] [Related]
15. Roundtable discussion: Part III--Hypertension management in health plans. Penna P; Cox E; Joseph T; Lehman L; Morrow T; Richter A; Sowers J; Tepper D Manag Care Interface; 2000; Suppl C():24-31. PubMed ID: 11183936 [TBL] [Abstract][Full Text] [Related]
16. The role of combination therapy in achieving blood pressure control. Neutel JM Am J Manag Care; 1999 Jun; 5(7 Suppl):S463-8. PubMed ID: 10538855 [No Abstract] [Full Text] [Related]
17. Health economics in drug therapy management. Navarro RP Med Interface; 1995 May; 8(5):127-8, 130. PubMed ID: 10142785 [No Abstract] [Full Text] [Related]
18. Drug-related morbidity and mortality: an economic and clinical perspective. Bootman JL Manag Care; 2002 Feb; 11(2 Suppl):12-5. PubMed ID: 11907995 [No Abstract] [Full Text] [Related]
20. Why managed care should provide supportive therapies for cancer patients. Rubenstein SA Manag Care; 1995 Aug; 4(8):37-9. PubMed ID: 10145013 [No Abstract] [Full Text] [Related] [Next] [New Search]